{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:41:20Z","timestamp":1761676880558,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejpb.2020.08.001","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T19:35:38Z","timestamp":1596915338000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin"],"prefix":"10.1016","volume":"155","author":[{"given":"Noriyasu","family":"Kamei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rio","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Tamiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Takeda-Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.08.001_b0005","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1023\/A:1012112219578","article-title":"Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate","volume":"14","author":"Lindmark","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.08.001_b0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","article-title":"Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic","volume":"61","author":"Maher","year":"2009","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.08.001_b0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biomaterials.2012.09.051","article-title":"Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells","volume":"34","author":"Krug","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2020.08.001_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11020078","article-title":"Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C10)","volume":"11","author":"Twarog","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2020.08.001_b0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejpb.2020.08.001_b0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2016.01.010","article-title":"Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts","volume":"101","author":"Moroz","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.08.001_b0035","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.febslet.2013.04.031","article-title":"Cell-penetrating peptides: 20 years later, where do we stand?","volume":"587","author":"Bechara","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejpb.2020.08.001_b0040","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2020.08.001_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020185","article-title":"Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos","volume":"17","author":"Kristensen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2020.08.001_b0050","doi-asserted-by":"crossref","unstructured":"E.J. Nielsen, S. Yoshida, N. Kamei, R. Iwamae, S. Khafagy el, J. Olsen, U.L. Rahbek, B.L. Pedersen, K. Takayama, M. Takeda-Morishita, In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin, J. Control. Release 189 (2014) 19\u201324.","DOI":"10.1016\/j.jconrel.2014.06.022"},{"key":"10.1016\/j.ejpb.2020.08.001_b0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1248\/bpb.b17-00798","article-title":"Exploration of the key factors for optimizing the in vivo oral delivery of insulin by using a noncovalent strategy with cell-penetrating peptides","volume":"41","author":"Kamei","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2020.08.001_b0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2009.02.015","article-title":"Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide\/protein absorption using cell-penetrating peptides","volume":"136","author":"Kamei","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.001_b0065","doi-asserted-by":"crossref","unstructured":"S. Khafagy el, M. Morishita, N. Kamei, Y. Eda, Y. Ikeno, K. Takayama, Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins, Int. J. Pharm. 381 (2009) 49\u201355.","DOI":"10.1016\/j.ijpharm.2009.07.022"},{"key":"10.1016\/j.ejpb.2020.08.001_b0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2006.12.022","article-title":"A novel approach using functional peptides for efficient intestinal absorption of insulin","volume":"118","author":"Morishita","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.001_b0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2008.08.001","article-title":"Usefulness of cell-penetrating peptides to improve intestinal insulin absorption","volume":"132","author":"Kamei","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.001_b0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nm996","article-title":"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis","volume":"10","author":"Wadia","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejpb.2020.08.001_b0085","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ymthe.2004.08.010","article-title":"Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement","volume":"10","author":"Nakase","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2020.08.001_b0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2004.10.018","article-title":"Cationic TAT peptide transduction domain enters cells by macropinocytosis","volume":"102","author":"Kaplan","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.001_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2020.08.001_b0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0962-8924(00)89101-1","article-title":"Macropinocytosis","volume":"5","author":"Swanson","year":"1995","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejpb.2020.08.001_b0105","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1242\/jcs.03238","article-title":"Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events","volume":"119","author":"Falcone","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejpb.2020.08.001_b0110","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1582-4934.2007.00062.x","article-title":"Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides","volume":"11","author":"Jones","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ejpb.2020.08.001_b0115","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/jps.23708","article-title":"Mechanistic study of the uptake\/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport","volume":"102","author":"Kamei","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.08.001_b0120","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1006\/bbrc.2000.4038","article-title":"Expression of specific markers and particle transport in a new human intestinal M-cell model","volume":"279","author":"Gullberg","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2020.08.001_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2012.01.041","article-title":"Comparative study of nanoparticle-mediated transfection in different GI epithelium co-culture models","volume":"160","author":"Loo","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.001_b0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2013.10.003","article-title":"Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies","volume":"458","author":"Ara\u00fajo","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.001_b0135","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/mp400507g","article-title":"Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles","volume":"11","author":"Schimpel","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.001_b0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J. Controll. Release : Off. J. Controll. Release Soc."},{"key":"10.1016\/j.ejpb.2020.08.001_b0145","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.6b01165","article-title":"Usefulness of Caco-2\/HT29-MTX and Caco-2\/HT29-MTX\/Raji B co-culture models to Predict Intestinal and Colonic Permeability compared to Caco-2 Monoculture","author":"Lozoya-Agullo","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.001_b0150","doi-asserted-by":"crossref","unstructured":"N. Kamei, Y. Aoyama, S. Khafagy el, M. Henmi, M. Takeda-Morishita, Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium, Eur. J. Pharm. Biopharm. 94 (2015) 42\u201351.","DOI":"10.1016\/j.ejpb.2015.04.030"},{"key":"10.1016\/j.ejpb.2020.08.001_b0155","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1039\/C5NR07474F","article-title":"Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery","volume":"8","author":"Hu","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2020.08.001_b0160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1016241610649","article-title":"Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2)","volume":"12","author":"Bai","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.08.001_b0165","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1023\/A:1016263926946","article-title":"Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium","volume":"12","author":"Bai","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.08.001_b0170","doi-asserted-by":"crossref","unstructured":"A. Beloqui, D.J. Brayden, P. Artursson, V. Preat, A. des Rieux, A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation, Nat. Protoc. 12 (2017) 1387\u20131399.","DOI":"10.1038\/nprot.2017.041"},{"key":"10.1016\/j.ejpb.2020.08.001_b0175","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1021\/bc015508l","article-title":"Stearylated arginine-rich peptides: a new class of transfection systems","volume":"12","author":"Futaki","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejpb.2020.08.001_b0180","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.08.001_b0185","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1021\/js960110x","article-title":"HT29-MTX\/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans","volume":"85","author":"Walter","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.08.001_b0190","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1286-4579(00)01266-1","article-title":"Molecular studies of the intestinal mucosal barrier physiopathology using cocultures of epithelial and immune cells: a technical update","volume":"2","author":"Kerneis","year":"2000","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ejpb.2020.08.001_b0195","doi-asserted-by":"crossref","first-page":"15300","DOI":"10.1074\/jbc.M401604200","article-title":"Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors","volume":"280","author":"Richard","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2020.08.001_b0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake","volume":"278","author":"Richard","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2020.08.001_b0205","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1021\/acs.bioconjchem.6b00082","article-title":"Syndecan-4 Is a receptor for clathrin-mediated endocytosis of arginine-rich cell-penetrating peptides","volume":"27","author":"Kawaguchi","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejpb.2020.08.001_b0210","doi-asserted-by":"crossref","first-page":"33957","DOI":"10.1074\/jbc.M109.056309","article-title":"Translocation and endocytosis for cell-penetrating peptide internalization","volume":"284","author":"Jiao","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2020.08.001_b0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol. Rev."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112030237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112030237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:38:17Z","timestamp":1760546297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112030237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":43,"alternative-id":["S093964112030237X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.08.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}